Literature DB >> 18640799

Callosal lesions and delirious behavior during febrile illness.

Akihisa Okumura1, Fumio Hayakawa, Toru Kato, Motomasa Suzuki, Takeshi Tsuji, Yukiko Fukumoto, Tomohiko Nakata, Kazuyoshi Watanabe, Tsuneo Morishima.   

Abstract

We retrospectively reviewed electroencephalography and magnetic resonance imaging findings for 21 children exhibiting delirious behavior during febrile illness. Among these, five patients had transient callosal lesions with or without white matter lesions on diffusion-weighted images. We compared the clinical characteristics, duration, and components of delirious behavior, the duration and severity of reduced consciousness, and EEG findings among patients with or without callosal lesions. No significant differences were detected in these items according to the presence or absence of callosal lesions. Adding insight into the pathogenesis of this condition, our study revealed that callosal lesions are not uncommon in patients exhibiting delirious behavior during febrile illness.

Entities:  

Mesh:

Year:  2008        PMID: 18640799     DOI: 10.1016/j.braindev.2008.06.002

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

Review 1.  Influenza encephalopathy and related neuropsychiatric syndromes.

Authors:  Masashi Mizuguchi
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

2.  Longitudinal diffusion changes following postoperative delirium in older people without dementia.

Authors:  Michele Cavallari; Weiying Dai; Charles R G Guttmann; Dominik S Meier; Long H Ngo; Tammy T Hshieh; Tamara G Fong; Eva Schmitt; Daniel Z Press; Thomas G Travison; Edward R Marcantonio; Richard N Jones; Sharon K Inouye; David C Alsop
Journal:  Neurology       Date:  2017-08-04       Impact factor: 9.910

3.  Cavernous angioma of the corpus callosum presenting with acute psychosis.

Authors:  Giacomo Pavesi; Francesco Causin; Alberto Feletti
Journal:  Behav Neurol       Date:  2014-03-05       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.